Oncology

Sub-standard and even falsified medicines are a well-known risk in international pharmaceutical supply chains. A recent Lancet article has brought attention on concerning results of in-market testing for available chemotherapy products in low- and middle-income countries (LMICs).

IDA Foundation and ATOM Coalition Join Forces to Bridge Gaps in Cancer Treatment Access through NCDconnect. IDA Foundation and the Access to Oncology Medicines (ATOM) Coalition are happy to announce their strategic partnership. Following World Cancer Day’s theme ‘Close the Care Gap’, this collaboration marks a significant step toward addressing the challenges of availability, affordability, and appropriate use of oncology medicines in low- and middle-income countries (LMICs).